Aligos Therapeutics (ALGS) Tax Provisions (2020 - 2026)
Aligos Therapeutics' (ALGS) quarterly Tax Provisions came in at $317000.0 in Q1 2026, up 637.21% YoY from $43000.0 in Q1 2025, and up 956.67% on a QoQ basis from $30000.0 in Q4 2025.
Aligos Therapeutics (ALGS) Tax Provisions (2020 - 2026) Analysis & Trends
Aligos Therapeutics (ALGS) has 7 years of Tax Provisions data on file, last reported at $317000.0 in Q1 2026.
- Quarterly Tax Provisions rose 637.21% year-over-year to $317000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $588000.0 (up 68.0% YoY) and the FY2025 annual result came in at $314000.0, down 5.14% from the prior year.
- Tax Provisions rose to $317000.0 in Q1 2026, from $30000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $757000.0 in Q2 2023 to a low of -$43000.0 in Q3 2022.
- A 5-year average of $109588.2 and a median of $47000.0 in 2022 frame the typical range for Tax Provisions.
- The widest YoY moves for Tax Provisions: up 1510.64% in 2023, down 161.22% in 2023.
- Tracing ALGS's Tax Provisions over 5 years: stood at $49000.0 in 2022, then plunged by 161.22% to -$30000.0 in 2023, then surged by 190.0% to $27000.0 in 2024, then rose by 11.11% to $30000.0 in 2025, then surged by 956.67% to $317000.0 in 2026.
- The last three Tax Provisions figures came in at $317000.0 (Q1 2026), $30000.0 (Q4 2025), and $56000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.93 Bn | 131.08 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 86.11 Bn | 78.11 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 65.43 Bn | 60.25 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 56.09 Bn | 50.96 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 42.13 Bn | 37.03 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | 13.31 Mn |
| 7 | BioNTech SE | 27.68 Bn | 9.29 Bn | 668.28 Mn | -90.33 Mn |
| 8 | Insmed | 27.49 Bn | 26.32 Bn | 358.27 Mn | 1.90 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | - |
| 10 | Aligos Therapeutics | 70.20 Mn | 39.76 Mn | - | 2.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.81 Mn |
| Mar 31, 2026 | 317,000.00 |
| Dec 31, 2025 | 30,000.00 |
| Sep 30, 2025 | 56,000.00 |
| Jun 30, 2025 | 185,000.00 |
| Mar 31, 2025 | 43,000.00 |
| Dec 31, 2024 | 27,000.00 |
| Sep 30, 2024 | 91,000.00 |
| Jun 30, 2024 | 189,000.00 |
| Mar 31, 2024 | 24,000.00 |
| Dec 31, 2023 | -30,000.00 |
| Sep 30, 2023 | 29,000.00 |
| Jun 30, 2023 | 757,000.00 |
| Mar 31, 2023 | 39,000.00 |
| Dec 31, 2022 | 49,000.00 |
| Sep 30, 2022 | -43,000.00 |
| Jun 30, 2022 | 47,000.00 |
| Mar 31, 2022 | 53,000.00 |
| Dec 31, 2021 | -58,000.00 |
| Sep 30, 2021 | 126,000.00 |